Cantuzumab mertansine [400010-39-1]

TargetMol Chemicals

Cantuzumab mertansine

9

Chemical

Research Use Only

Cantuzumab mertansine

Cantuzumab mertansine (SB-408075; huC242-DM1), an antibody-drug conjugate (ADC), comprises the potent maytansine derivative (DM1) linked to the humanized monoclonal antibody (huC242) targeting CanAg. Demonstrating cytotoxicity against colon cancer cells, this compound shows extensive antitumor effectiveness across various CanAg-positive human tumor xenografts [1] [2].

3 years

-20°C

12352203